Edition:
United States

Endo International PLC (ENDP.OQ)

ENDP.OQ on NASDAQ Stock Exchange Global Select Market

13.14USD
1:36pm EST
Change (% chg)

$0.05 (+0.42%)
Prev Close
$13.08
Open
$13.10
Day's High
$13.24
Day's Low
$13.02
Volume
726,394
Avg. Vol
1,528,931
52-wk High
$54.78
52-wk Low
$11.37

ENDP.OQ

Chart for ENDP.OQ

About

Endo International plc is a global specialty pharmaceutical company focused on developing, manufacturing, marketing and distributing branded and generic pharmaceutical products, as well as over-the-counter medications through its operating companies- Endo Pharmaceuticals, Par Pharmaceutical, Paladin Labs and SOMAR. The Company’s... (more)

Overall

Beta: 0.57
Market Cap(Mil.): $2,915.23
Shares Outstanding(Mil.): 222.88
Dividend: --
Yield (%): --

Financials

  ENDP.OQ Industry Sector
P/E (TTM): 5.29 28.39 29.32
EPS (TTM): 2.47 -- --
ROI: 3.40 13.54 13.03
ROE: 8.89 14.43 14.17

Endo International CEO steps down, Campanelli named successor

Endo International Plc said Chief Executive Rajiv De Silva had stepped down and would be replaced by generics division head Paul Campanelli, as the drugmaker grapples with a large debt load and mounting pressure on some of its drug prices.

Sep 23 2016

Endo International CEO steps down; Campanelli named successor

Sept 23 Drugmaker Endo International Plc said on Friday Chief Executive and President Rajiv De Silva had stepped down, and named Paul Campanelli as his successor.

Sep 23 2016

More From Around the Web

Earnings vs. Estimates